• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于经皮吸收的卡托普利羧酸酯衍生物的代谢

Metabolism of captopril carboxyl ester derivatives for percutaneous absorption.

作者信息

Gullick Darren R, Ingram Matthew J, Pugh W John, Cox Paul A, Gard Paul, Smart John D, Moss Gary P

机构信息

School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.

出版信息

J Pharm Pharmacol. 2009 Feb;61(2):159-65. doi: 10.1211/jpp/61.02.0004.

DOI:10.1211/jpp/61.02.0004
PMID:19178762
Abstract

OBJECTIVES

To determine the metabolism of captopril n-carboxyl derivatives and how this may impact on their use as transdermal prodrugs. The pharmacological activity of the ester derivatives was also characterised in order to compare the angiotensin converting enzyme inhibitory potency of the derivatives compared with the parent drug, captopril.

METHODS

The metabolism rates of the ester derivatives were determined in vitro (using porcine liver esterase and porcine ear skin) and in silico (using molecular modelling to investigate the potential to predict metabolism).

KEY FINDINGS

Relatively slow pseudo first-order metabolism of the prodrugs was observed, with the ethyl ester displaying the highest rate of metabolism. A strong relationship was established between in-vitro methods, while in-silico methods support the use of in-vitro methods and highlight the potential of in-silico techniques to predict metabolism. All the prodrugs behaved as angiotensin converting enzyme inhibitors, with the methyl ester displaying optimum inhibition.

CONCLUSIONS

In-vitro porcine liver esterase metabolism rates inform in-vitro skin rates well, and in-silico interaction energies relate well to both. Thus, in-silico methods may be developed that include interaction energies to predict metabolism rates.

摘要

目的

确定卡托普利N - 羧基衍生物的代谢情况,以及这可能如何影响它们作为透皮前药的应用。还对酯衍生物的药理活性进行了表征,以便比较这些衍生物与母体药物卡托普利的血管紧张素转换酶抑制效力。

方法

在体外(使用猪肝酯酶和猪耳皮肤)和计算机模拟(使用分子建模来研究预测代谢的潜力)中测定酯衍生物的代谢速率。

主要发现

观察到前药相对缓慢的伪一级代谢,其中乙酯显示出最高的代谢速率。体外方法之间建立了很强的关系,而计算机模拟方法支持体外方法的使用,并突出了计算机模拟技术预测代谢的潜力。所有前药均表现为血管紧张素转换酶抑制剂,其中甲酯显示出最佳抑制效果。

结论

体外猪肝酯酶代谢速率能很好地反映体外皮肤代谢速率,计算机模拟相互作用能与两者都有很好的相关性。因此,可以开发包括相互作用能来预测代谢速率的计算机模拟方法。

相似文献

1
Metabolism of captopril carboxyl ester derivatives for percutaneous absorption.用于经皮吸收的卡托普利羧酸酯衍生物的代谢
J Pharm Pharmacol. 2009 Feb;61(2):159-65. doi: 10.1211/jpp/61.02.0004.
2
Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption.用于增强经皮吸收的卡托普利前药的设计、合成与表征
J Pharm Pharmacol. 2006 Feb;58(2):167-77. doi: 10.1211/jpp.58.2.0003.
3
The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme.
Bioorg Med Chem Lett. 2006 Oct 1;16(19):5084-7. doi: 10.1016/j.bmcl.2006.07.034. Epub 2006 Aug 2.
4
Synthesis of glabridin derivatives as tyrosinase inhibitors.光甘草定衍生物作为酪氨酸酶抑制剂的合成。
Arch Pharm Res. 2009 May;32(5):647-54. doi: 10.1007/s12272-009-1501-x. Epub 2009 May 27.
5
Impact of ester promoieties on transdermal delivery of ketorolac.酯基部分对酮咯酸透皮给药的影响。
J Pharm Sci. 2014 Mar;103(3):974-86. doi: 10.1002/jps.23888. Epub 2014 Jan 30.
6
Alpha-tocopherol pro-vitamins: synthesis, hydrolysis and accumulation in rabbit ear skin.α-生育酚原维生素:在兔耳皮肤中的合成、水解与积累
J Control Release. 2004 Oct 19;99(3):403-13. doi: 10.1016/j.jconrel.2004.08.002.
7
Percutaneous absorption of captopril from hydrophilic cellulose derivatives through excised rabbit skin and human skin.卡托普利通过切除的兔皮和人皮从亲水性纤维素衍生物中的经皮吸收。
Drug Dev Ind Pharm. 1998 Feb;24(2):179-82. doi: 10.3109/03639049809085604.
8
Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.新型含三氟甲基的血管紧张素转换酶抑制剂的设计、合成及酶抑制活性
Drug Des Discov. 1994 Feb;11(2):91-113.
9
Matrix type transdermal therapeutic system containing captopril: formulation optimization, in vitro and ex vivo characterization.含卡托普利的基质型透皮治疗系统:制剂优化、体外和离体表征
Acta Pol Pharm. 2013 Mar-Apr;70(2):291-300.
10
Synthesis and biological evaluation of proline derivatives as potential angiotensin converting enzyme inhibitor.脯氨酸衍生物作为潜在血管紧张素转换酶抑制剂的合成与生物学评价
Boll Soc Ital Biol Sper. 1996 Jan-Feb;72(1-2):29-36.